Kosan Biosciences Inc., of Hayward, Calif., was awarded U.S. Patent No...Symyx Technologies Inc., of Santa Clara, Calif., was issued U.S. Patent No...Vical Inc., of San Diego, was issued U.S. Patent No

Acusphere Inc., of Watertown, Mass., was issued U.S. Patent No...Dendreon Corp., of Seattle, was awarded U.S. Patent No...The company also was granted U.S. Patent No

Cepheid Inc., of Sunnyvale, Calif., was issued U.S. Patent No...PhageTech Inc., of Montreal, was issued U.S. Patent No...Zyomyx Inc., of Hayward, Calif., was awarded U.S. Patent No

Hybridon Inc., of Cambridge, Mass., was issued U.S. Patent No...PerkinElmer Inc., of Boston, was issued U.S. Patent No...Pharmacor Inc., of Montreal, was issued U.S. Patent No

Nereus Pharmaceuticals Inc., of San Diego, was issued U.S. Patent No...SemBioSys Inc., of Calgary, Alberta, was granted U.S. Patent No...Vical Inc., of San Diego, was issued U.S. Patent No

Applied Gene Technologies also was awarded U.S. Patent No...Avigen Inc., of Alameda, Calif., was awarded U.S. Patent No...The company also was awarded U.S. Patent No

Cepheid Inc., of Sunnyvale, Calif., was issued U.S. Patent No...Genset SA, of Paris, was issued U.S. Patent No...ZymoGenetics Inc., of Seattle, was issued U.S. Patent Nos

Athersys Inc., of Cleveland, was issued U.S. Patent No...Avigen Inc., of Alameda, Calif., was awarded U.S. Patent No...Cepheid Inc., of Sunnyvale, Calif., was issued U.S. Patent No

Diversa Corp., of San Diego, was issued U.S. Patent No...U.S. Genomics Inc., of Woburn, Mass., was issued U.S. Patent No...Viragen Inc., of Plantation, Fla., was issued U.S. Patent No

Hybridon Inc., of Cambridge, Mass., reported that the University of Massachusetts was issued U.S. Patent No...Isis Pharmaceuticals Inc., of Carlsbad, Calif., acquired a license to the patent, and others, in May 2001, from Hybridon, which included exclusive rights to sublicense the patents to third parties

Alexion Pharmaceuticals Inc., of Cheshire, Conn., was issued U.S. Patent No...Diversa Corp., of San Diego, was issued U.S. Patent No...Signature BioScience also was issued U.S. Patent No

Merrimack Pharmaceuticals Inc., of Cambridge, Mass., said U.S. Patent No...Microbiotix Inc., of Worcester, Mass., was issued U.S. Patent No...Peregrine Pharmaceuticals Inc., of Tustin, Calif., was issued U.S. Patent No

Neurochem Inc., of Saint-Laurent, Quebec, was issued U.S. Patent No...ProtoTech Inc., of Kirkland, Wash., said U.S. Patent No...Ribozyme Pharmaceuticals Inc., of Boulder, Colo., was issued U.S. Patent No

BioSyntech Inc., of Laval, Quebec, was issued U.S. Patent No...Sunesis Pharmaceuticals Inc., of South San Francisco, was issued U.S. Patent No...Vaxin Inc., of Birmingham, Ala., received U.S. Patent No

Lorus Therapeutics Inc., of Toronto, said the U.S. Patent and Trademark Office allowed a patent covering a component of its antisense drug development program that demonstrated promising anticancer properties in preclinical studies...NeoTherapeutics Inc., of Irvine, Calif., was granted U.S. Patent No...Targeted Genetics Corp., of Seattle, was issued U.S. Patent No

Galapagos Genomics NV, of Mechelen, Belgium, was awarded U.S. Patent No...ImmunoGen Inc., of Cambridge, Mass., was awarded U.S. Patent No...Targeted Genetics Corp., of Seattle, reported that U.S. Patent No

BioTrove Inc., of Cambridge, Mass., was issued U.S. Patent No...Celgene Corp., of Warren, N.J., was issued U.S. Patent No...Copernicus Therapeutics Inc., of Cleveland, was awarded U.S. Patent No

Targepeutics Inc., of Hershey, Pa., was issued U.S. Patent No...Targeted Genetics Corp., of Seattle, said U.S. Patent No...Zyomyx Inc., of Hayward, Calif., was awarded U.S. Patent No

Bioheart Inc., of Weston, Fla., was issued U.S. Patent No...ImmunoGen Inc., of Cambridge, Mass., was issued U.S. Patent No...Symphogen A/S, of Copenhagen, Denmark, said Boston University was issued U.S. Patent No